News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

ProTip SAS Receives Prestigious European Award for its Biomaterial Research Program



9/29/2011 12:19:34 PM

Strasbourg, France, September 29, 2011 - ProTip SA, a company developing medical devices that bring innovative solutions to people suffering from dysfunctions of the larynx, announces today that it was awarded the ESB Translational Research prize of the European Society for Biomaterials at the ESB annual congress in Dublin (Ireland) September 4-8. This prize, sponsored by the Swiss Society for Biomaterials, is designed to “support scientific efforts in translational research, i.e. scientific activities helping to transform a research idea into a product.”

This prize has been awarded for a research program launched by ProTip in 2010, aimed at developing a trachea implant made from a biodegradable microporous polymer and macroporous titanium. This program is being led by Dr. Nihal Engin Vrana, a post-doctorate researcher specialized in the development of biomaterials that is now working for ProTip. The program is also in association with the Inserm Biomaterials and Tissue Engineering laboratory in Strasbourg. This distinction confirms ProTip’s proven potential for developing an innovative solution based on porous titanium for thousands of patients who have undergone a partial or total laryngectomy.

“We are very proud to have been awarded this particular prize, as it is a strong mark of peer recognition,” said Dr. Nihal Engin Vrana, who presented the ProTip project at the ESB congress. “The award demonstrates recognition for our ability to undertake a research program that generates concrete solutions for patients, while maintaining high scientific standards. It is also proof that ProTip knows how to balance its short-term corporate goals with the long-term scientific objectives of Inserm.” Inserm is the French National Health and Medical Research Institute.

“This reward proves that, with high enough focus on relevant and the right research activities, a young firm like ProTip can play an important role in a market as demanding and competitive as that of biomaterials,” said the chairman of ProTip SA, Maurice Bérenger.

About the European Society for Biomaterials

The European Society for Biomaterials (ESB) is a non-profit scientific society whose main objective is to encourage progress in the field of biomaterials in all its aspects, including research, teaching and clinical applications, as well as to foster any other related activity. It was founded in March 1976 and became a member of the International Union of Societies for Biomaterials Sciences and Engineering (IUS-BSE) at its conception in 1979. The ESB has approximately 750 members from 32 different countries worldwide.

Every year the ESB, in partnership with the Swiss Society for Biomaterials, awards a prize for translational research.

For further information, go to: http://www.esbiomaterials.eu

About ProTip SA

ProTip SA is a privately held medical device company dedicated to finding innovative solutions for patients suffering from malfunctions of the larynx. Its initial focus is to develop a permanent implant for patients having undergone a laryngectomy.

Based in Strasbourg, in the Alsace region of eastern France, ProTip was founded in 2004. It has been strongly supported by the Alsace region and Oseo, the French government innovation agency, and has won several prestigious awards in France. It has established partnerships with a number of international research establishments and has put together an experienced management team to speed up the company’s international development.

For further information, go to: http://www.protipmedical.com

Mark Tidmarsh

ANDREW LLOYD & ASSOCIATES

http://www.ala.com

mark@ala.com

Brighton Business Centre 95 Ditchling Road Brighton BN1 4ST ENGLAND

Tel: +44 1273 675100

Fax: +44 1273 675400

55 rue Boissonade 75014 Paris FRANCE

Tel: +33 1 56 54 07 00

Fax: +33 1 56 54 07 01

INTERNATIONAL TECHNOLOGY MARKETS, STRATEGY & COMMUNICATION


Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES